News
IXHL
0.7000
+720.63%
0.6147
Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?
Benzinga · 6h ago
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings
Benzinga · 12h ago
Incannex provides clinical update on IHL-42X
TipRanks · 13h ago
Incannex Completes Patient Dosing in Phase 2 Study
TipRanks · 13h ago
INCANNEX HEALTHCARE INC. PROVIDES CLINICAL PROGRAM UPDATE ON IHL-42X, AN ORAL ONCE-DAILY TREATMENT FOR OBSTRUCTIVE SLEEP APNEA (OSA)
Reuters · 14h ago
INCANNEX HEALTHCARE INC: TOPLINE RESULTS EXPECTED IN JULY 2025
Reuters · 14h ago
Weekly Report: what happened at IXHL last week (0505-0509)?
Weekly Report · 2d ago
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Weekly Report: what happened at IXHL last week (0428-0502)?
Weekly Report · 05/05 09:54
BUZZ-U.S. STOCKS ON THE MOVE-Smithfield Foods, Altria, Sherwin-Willams
Reuters · 04/29 17:59
BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, Hims & Hers, Okta
Reuters · 04/29 15:46
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
Benzinga · 04/29 14:20
Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/29 09:15
Weekly Report: what happened at IXHL last week (0421-0425)?
Weekly Report · 04/28 09:58
Weekly Report: what happened at IXHL last week (0414-0418)?
Weekly Report · 04/21 09:58
Weekly Report: what happened at IXHL last week (0407-0411)?
Weekly Report · 04/14 09:54
Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/09 08:58
Weekly Report: what happened at IXHL last week (0331-0404)?
Weekly Report · 04/07 09:54
Psychedelic: Enveric, Filament Health report earnings results
TipRanks · 04/03 15:40
Incannex completes Phase 2 patient enrollment for RePOSA study of IHL-42X
TipRanks · 04/03 11:36
More
Webull provides a variety of real-time IXHL stock news. You can receive the latest news about Incannex Healthcare Ltd through multiple platforms. This information may help you make smarter investment decisions.
About IXHL
More
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
Recently
Symbol
Price
%Change